Regeneron Pharmaceuticals, Inc. (REGN)Stock price, Description, News & Info

#Thinksabio latest news

Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agonist-induced Weight Loss by Preserving Lean Mass, Presented at EASD